Regulatory Affairs & Intellectual Property Rights

Regulatory Affairs has a very specific meaning within the healthcare industries . It's regulations are for systematic manufacturing and marketing of safe, efficacious and qualitative drugs. Improving  new regulations and adopting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation .

The market is expected to expand at a substantial 11.5% CAGR from 2015 to 2023 and rise to a valuation of US$5.7 billion by 2023.

  • Regulatory Affairs Filing and Documentation
  • Enhancing Regulatory Science for Public Health
  • Meeting the Challenges for Regulating
  • Patent and types of Patent Application
  • Copyrights
  • Trademark
  • Infringement
  • Iprs and Market for Technology
  • Role of Patent Co-operation Therapy

Related Conference of Regulatory Affairs & Intellectual Property Rights

October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Regulatory Affairs & Intellectual Property Rights Conference Speakers

Recommended Sessions

Related Journals

Are you interested in